USD 0.77
(-1.16%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 1.41 Billion CNY | -5.3% |
2022 | 1.49 Billion CNY | 33.7% |
2021 | 1.12 Billion CNY | 46.26% |
2020 | 766.52 Million CNY | 57.63% |
2019 | 486.27 Million CNY | 130.64% |
2018 | 210.83 Million CNY | 46.36% |
2017 | 144.05 Million CNY | 6.92% |
2016 | 134.73 Million CNY | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 1.36 Billion CNY | -4.58% |
2024 Q1 | 1.43 Billion CNY | 0.94% |
2023 Q3 | 1.48 Billion CNY | 6.75% |
2023 FY | 1.41 Billion CNY | -5.3% |
2023 Q1 | 1.46 Billion CNY | -2.05% |
2023 Q4 | 1.41 Billion CNY | -4.18% |
2023 Q2 | 1.38 Billion CNY | -5.48% |
2022 Q1 | 1.09 Billion CNY | -2.07% |
2022 Q4 | 1.49 Billion CNY | 20.74% |
2022 FY | 1.49 Billion CNY | 33.7% |
2022 Q2 | 1.22 Billion CNY | 11.45% |
2022 Q3 | 1.24 Billion CNY | 1.46% |
2021 Q4 | 1.12 Billion CNY | 12.94% |
2021 FY | 1.12 Billion CNY | 46.26% |
2021 Q3 | 992.65 Million CNY | -1.22% |
2021 Q2 | 1 Billion CNY | -2.65% |
2021 Q1 | 1.03 Billion CNY | 34.67% |
2020 Q4 | 766.52 Million CNY | -16.95% |
2020 Q2 | 599.86 Million CNY | -7.15% |
2020 FY | 766.52 Million CNY | 57.63% |
2020 Q1 | 646.02 Million CNY | 32.85% |
2020 Q3 | 922.91 Million CNY | 53.85% |
2019 Q3 | 441.43 Million CNY | 4.87% |
2019 Q2 | 420.91 Million CNY | 58.6% |
2019 Q1 | 265.39 Million CNY | 25.88% |
2019 Q4 | 486.27 Million CNY | 10.16% |
2019 FY | 486.27 Million CNY | 130.64% |
2018 Q2 | 182.08 Million CNY | 9.21% |
2018 FY | 210.83 Million CNY | 46.36% |
2018 Q4 | 210.83 Million CNY | -10.61% |
2018 Q1 | 166.73 Million CNY | 15.74% |
2018 Q3 | 235.85 Million CNY | 29.53% |
2017 FY | 144.05 Million CNY | 6.92% |
2017 Q1 | - CNY | 0.0% |
2017 Q4 | 144.05 Million CNY | 0.0% |
2016 FY | 134.73 Million CNY | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
CannBioRx Life Sciences Corp. | - USD | -Infinity% |
BIMI International Medical Inc. | 7.65 Million USD | -18443.913% |
China Jo-Jo Drugstores, Inc. | 17.16 Million USD | -8170.021% |
Harrow Health, Inc. 8.625% Senior Notes due 2026 | 10.86 Million USD | -12961.526% |
Harrow Health, Inc. 11.875% Senior Notes due 2027 | 10.86 Million USD | -12961.526% |
Leafly Holdings, Inc. | - USD | -Infinity% |
Leafly Holdings, Inc. | - USD | -Infinity% |
LifeMD, Inc. | 2.75 Million USD | -51328.658% |
LifeMD, Inc. | 2.75 Million USD | -51328.658% |
TRxADE HEALTH, Inc. | 968.00 USD | -146631718.182% |
PetMed Express, Inc. | 28.55 Million USD | -4870.57% |
Walgreens Boots Alliance, Inc. | 8.32 Billion USD | 82.94% |